» Articles » PMID: 36768664

Extracellular Vesicles As Therapeutic Resources in the Clinical Environment

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Feb 11
PMID 36768664
Authors
Affiliations
Soon will be listed here.
Abstract

The native role of extracellular vesicles (EVs) in mediating the transfer of biomolecules between cells has raised the possibility to use them as therapeutic vehicles. The development of therapies based on EVs is now expanding rapidly; here we will describe the current knowledge on different key points regarding the use of EVs in a clinical setting. These points are related to cell sources of EVs, isolation, storage, and delivery methods, as well as modifications to the releasing cells for improved production of EVs. Finally, we will depict the application of EVs therapies in clinical trials, considering the impact of the COVID-19 pandemic on the development of these therapies, pointing out that although it is a promising therapy for human diseases, we are still in the initial phase of its application to patients.

Citing Articles

Extracellular Vesicles as Biomarkers in Infectious Diseases.

Cruz C, Sodawalla H, Mohanakumar T, Bansal S Biology (Basel). 2025; 14(2).

PMID: 40001950 PMC: 11851951. DOI: 10.3390/biology14020182.


Extracellular Vesicles as Mediators of Endothelial Dysfunction in Cardiovascular Diseases.

Jimenez-Trinidad F, Calvo-Gomez S, Sabate M, Brugaletta S, Campuzano V, Egea G Int J Mol Sci. 2025; 26(3).

PMID: 39940780 PMC: 11816526. DOI: 10.3390/ijms26031008.


Microvesicles Released by Osteoclastic Cells Exhibited Chondrogenic, Osteogenic, and Anti-Inflammatory Activities: An Evaluation of the Feasibility of Their Use for Treatment of Osteoarthritis in a Mouse Model.

Sheng M, Rundle C, Lau K Cells. 2025; 14(3).

PMID: 39936984 PMC: 11817440. DOI: 10.3390/cells14030193.


Melanoma-derived extracellular vesicles transfer proangiogenic factors.

Wilczak M, Surman M, PRZYBYlO M Oncol Res. 2025; 33(2):245-262.

PMID: 39866233 PMC: 11753996. DOI: 10.32604/or.2024.055449.


Emerging Strategies for Revascularization: Use of Cell-Derived Extracellular Vesicles and Artificial Nanovesicles in Critical Limb Ischemia.

Ravi Mythili V, Rajendran R, Arun R, Loganathbabu V, Reyaz D, Nagarajan A Bioengineering (Basel). 2025; 12(1).

PMID: 39851366 PMC: 11762151. DOI: 10.3390/bioengineering12010092.


References
1.
Zhang S, Chu W, Lai R, Lim S, Hui J, Toh W . Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthritis Cartilage. 2016; 24(12):2135-2140. DOI: 10.1016/j.joca.2016.06.022. View

2.
Reiner A, Somoza V . Extracellular Vesicles as Vehicles for the Delivery of Food Bioactives. J Agric Food Chem. 2019; 67(8):2113-2119. DOI: 10.1021/acs.jafc.8b06369. View

3.
Zhu Y, Shi M, Monsel A, Dai C, Dong X, Shen H . Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study. Stem Cell Res Ther. 2022; 13(1):220. PMC: 9135389. DOI: 10.1186/s13287-022-02900-5. View

4.
Thomi G, Surbek D, Haesler V, Joerger-Messerli M, Schoeberlein A . Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury. Stem Cell Res Ther. 2019; 10(1):105. PMC: 6429800. DOI: 10.1186/s13287-019-1207-z. View

5.
Mendt M, Kamerkar S, Sugimoto H, McAndrews K, Wu C, Gagea M . Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 2018; 3(8). PMC: 5931131. DOI: 10.1172/jci.insight.99263. View